Human Solid Plasma (HSP) is an autologous and pure biological matrix approach based on the principle of converting the patient's own plasma-serum proteins — particularly the albumin fraction — into a semi-solid form through controlled heat denaturation.
Unlike the synthetic filler concept, HSP aims to form a biocompatible, additive-free, and entirely autologous protein matrix. With its patented invention technology, it can be evaluated by physicians across different fields such as dermatology, medical aesthetics, gynecology, and chronic wound support.
Obtained entirely from your own blood. Contains no foreign material, animal source, or chemical additives.
No heparin, citrate, or other anticoagulants are used. A pure plasma-serum protein matrix is formed.
Beyond being just a volume-providing material; a protein scaffold that can stimulate micro-regenerative response and support collagen synthesis.
Application potential across different areas such as dermatology, gynecology, chronic wound, and meniscus applications.
A small amount of blood sample is taken from the patient under sterile conditions.
The blood sample is processed in a centrifuge device at controlled speed and duration.
The plasma-serum component is separated as a result of centrifugation; growth factors and proteins are in this phase.
The obtained plasma is drawn into a syringe and loaded through the input of the HSP device.
The device completes controlled thermal denaturation; the albumin fraction transitions to a semi-solid form.
Human Solid Plasma is now ready for use by the physician according to clinical indication.
Biological support for skin rejuvenation and aesthetic applications; an autologous approach that improves tissue quality and supports collagen synthesis.
More InformationFormation of a protein matrix in the wound bed; biological support for granulation tissue and angiogenesis processes.
More InformationVaginal rejuvenation, labioplasty-supported volume, and stress urinary incontinence support protocols.
More InformationInstead of synthetic fillers, a pure autologous protein matrix; HSP as a new concept in regenerative medicine.
More InformationWhile developing HSP, our goal was not a theoretical concept but a system that responds to physician needs in the field — one that is clinically realistic, autologous, and sustainable.
Mesut Karahan has been actively working in the healthcare sector since 1997. He has long-standing field experience in technical service management, hospital operation processes, diagnostic systems, and medical aesthetics.
This accumulation has enabled Human Solid Plasma to be developed not as a mere theoretical concept, but as a system suitable for clinical realities, applicable in the field, and responsive to physician needs. HSP was developed by Karahan as a patented invention technology and designed with a multidisciplinary use vision.
For details about Human Solid Plasma technology, preparation process, application areas, and clinical advantages, you can examine our catalog content.